| Source | WTTW |
|---|---|
| Original Load Date | April 24, 2026, 1:01 p.m. |
| Last Updated | April 24, 2026, 1:01 p.m. |
| Original URL | https://news.wttw.com/2026/04/24/fda-plans-ultra-fast-review-three-psychedelic-drugs-following-trump-directive |
Article Preview
WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer
ultra-fast review to three psychedelic drugs being developed to treat mental
health conditions, including depression, the latest step by the Trump
administration toward possible approval of the experimental treatments.
Pre...